Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 544
Filter
1.
BMC Complement Med Ther ; 24(1): 213, 2024 Jun 04.
Article in English | MEDLINE | ID: mdl-38835032

ABSTRACT

BACKGROUND: Gastrodin (GAS), a main bioactive component of the herbal plant, Gastrodia elata Blume, has shown to have beneficial effects on neuroinflammatory diseases such as Alzheimer's disease in animal studies and migraine in clinical studies. Inflammasome is a multimeric protein complex having a core of pattern recognition receptor and has been implicated in the development of neuroinflammatory diseases. Gastrodin has shown to modulate the activation of nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome. This study investigated the effects of GAS on the intensity of mechanical allodynia and associated changes in NLRP3 inflammasome expression at the spinal level using L5/6 spinal nerve ligation model (SNL) in rats. METHODS: Intrathecal (IT) catheter implantation and SNL were used for drug administration and pain model in male Sprague-Dawley rats. The effect of gastrodin or MCC950 (NLRP3 inflammasome inhibitor) on mechanical allodynia was measured by von Frey test. Changes in NLRP3 inflammasome components and interleukin-1ß (IL-1ß) and cellular expression were examined in the spinal cord and dorsal root ganglion. RESULTS: The expression of NLRP3 inflammasome components was found mostly in the neurons in the spinal cord and dorsal root ganglion. The protein and mRNA levels of NLRP3, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), caspase-1, and IL-1ß were upregulated in SNL animals compared to Sham animals. IT administration of GAS significantly attenuated the expression of NLRP3 inflammasome and the intensity of SNL-induced mechanical allodynia. NLRP3 inflammasome inhibitor, MCC950, also attenuated the intensity of allodynia, but the effect is less strong and shorter than that of GAS. CONCLUSIONS: Expression of NLRP3 inflammasome and IL-1ß is greatly increased and mostly found in the neurons at the spinal level in SNL model, and IT gastrodin exerts a significant anti-allodynic effect in SNL model partly through suppressing the expression of NLRP3 inflammasome.


Subject(s)
Benzyl Alcohols , Disease Models, Animal , Glucosides , Hyperalgesia , Inflammasomes , NLR Family, Pyrin Domain-Containing 3 Protein , Rats, Sprague-Dawley , Animals , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Benzyl Alcohols/pharmacology , Glucosides/pharmacology , Male , Rats , Inflammasomes/metabolism , Inflammasomes/drug effects , Hyperalgesia/drug therapy , Spinal Nerves/drug effects , Injections, Spinal
2.
Mol Pain ; 20: 17448069241256466, 2024.
Article in English | MEDLINE | ID: mdl-38716504

ABSTRACT

Background: Recent studies have shown that peripheral nerve regeneration process is closely related to neuropathic pain. Toll-like receptor 4 (TLR4) signaling was involved in different types of pain and nerve regeneration. TLR4 induced the recruitment of myeloid differentiation factor-88 adaptor protein (MyD88) and NF-κB-depended transcriptional process in sensory neurons and glial cells, which produced multiple cytokines and promoted the induction and persistence of pain. Our study aimed to investigate procyanidins's effect on pain and nerve regeneration via TLR4-Myd88 signaling. Methods: Spinal nerve ligation (SNL) model was established to measure the analgesic effect of procyanidins. Anatomical measurement of peripheral nerve regeneration was measured by microscopy and growth associated protein 43 (GAP43) staining. Western blotting and/or immunofluorescent staining were utilized to detect TLR4, myeloid differentiation factor-88 adaptor protein (MyD88), ionized calcium-binding adapter molecule 1 (IBA1) and nuclear factor kappa-B-p65 (NF-κB-p65) expression, as well as the activation of astrocyte and microglia. The antagonist of TLR4 (LPS-RS-Ultra, LRU) were intrathecally administrated to assess the behavioral effects of blocking TLR4 signaling on pain and nerve regeneration. Result: Procyanidins reduced mechanical allodynia, thermal hyperalgesia and significantly suppressed the number of nerve fibers regenerated and the degree of myelination in SNL model. Compared with sham group, TLR4, MyD88, IBA1 and phosphorylation of NF-κB-p65 were upregulated in SNL rats which were reversed by procyanidins administration. Additionally, procyanidins also suppressed activation of spinal astrocytes and glial cells. Conclusion: Suppression of TLR4-MyD88 signaling contributes to the alleviation of neuropathic pain and reduction of nerve regeneration by procyanidins.


Subject(s)
Myeloid Differentiation Factor 88 , Nerve Regeneration , Neuralgia , Proanthocyanidins , Rats, Sprague-Dawley , Signal Transduction , Toll-Like Receptor 4 , Animals , Proanthocyanidins/pharmacology , Toll-Like Receptor 4/metabolism , Neuralgia/drug therapy , Neuralgia/metabolism , Myeloid Differentiation Factor 88/metabolism , Nerve Regeneration/drug effects , Signal Transduction/drug effects , Male , Grape Seed Extract/pharmacology , Rats , Microglia/drug effects , Microglia/metabolism , Astrocytes/drug effects , Astrocytes/metabolism , Spinal Nerves/drug effects
3.
Neuropharmacology ; 252: 109939, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38570065

ABSTRACT

To investigate the efficacy of Ursolic acid in alleviating neuropathic pain in rats with spinal nerve ligation (SNL), the SNL rat model was surgically induced. Different concentrations of Ursolic acid and manipulated target mitogen-activated protein kinase 1 (MAPK1) were administered to the SNL rats. Fecal samples were collected from each group of rats for 16S rDNA analysis to examine the impact of gut microbiota. Molecular docking experiments were conducted to assess the binding energy between Ursolic acid and MAPK1. In vivo studies were carried out to evaluate the expression of inflammatory factors and signaling pathways in spinal cord and colon tissues. Ursolic acid was found to have a beneficial effect on pain reduction in rats by increasing plantar withdrawal latency (PWL) and paw withdrawal threshold (PWT). Comparing the Ursolic acid group with the control group revealed notable differences in the distribution of Staphylococcus, Allobaculum, Clostridium, Blautia, Bifidobacterium, and Prevotella species. Network pharmacology analysis identified MAPK1 and intercellular adhesion molecule-1 (ICAM1) as common targets for Ursolic acid, SNL, and neuropathic pain. Binding sites between Ursolic acid and these targets were identified. Additionally, immunofluorescent staining showed a decrease in GFAP and IBA1 intensity in the spinal cord along with an increase in NeuN following Ursolic acid treatment. Overexpression of MAPK1 in SNL rats led to an increase in inflammatory factors and a decrease in PWL and PWT. Furthermore, MAPK1 counteracted the pain-relieving effects of Ursolic acid in SNL rats. Ursolic acid was found to alleviate neuropathic pain in SNL rats by targeting MAPK1 and influencing gut microbiota homeostasis.


Subject(s)
Antigens, Nuclear , Gastrointestinal Microbiome , Mitogen-Activated Protein Kinase 1 , Nerve Tissue Proteins , Neuralgia , Rats, Sprague-Dawley , Triterpenes , Ursolic Acid , Animals , Neuralgia/drug therapy , Neuralgia/metabolism , Triterpenes/pharmacology , Gastrointestinal Microbiome/drug effects , Male , Mitogen-Activated Protein Kinase 1/metabolism , Rats , Spinal Cord/drug effects , Spinal Cord/metabolism , Molecular Docking Simulation , Disease Models, Animal , Spinal Nerves/drug effects , Analgesics/pharmacology , Colon/drug effects , Colon/microbiology , Colon/metabolism , Glial Fibrillary Acidic Protein/metabolism
4.
Neural Plast ; 2021: 9923537, 2021.
Article in English | MEDLINE | ID: mdl-34512747

ABSTRACT

Background: Neuropathic pain is a common chronic pain, which is related to hypersensitivity to stimulus and greatly affects the quality of life of patients. Maladaptive gene changes and molecular signaling underlie the sensitization of nociceptive pathways. We previously found that the activation of microglial glucagon-like peptide 1 receptor (GLP-1R) could potently relieve formalin-, bone cancer-, peripheral nerve injury-, and diabetes-induced pain hypersensitivity. So far, little is known about how the gene profile changes upon the activation of GLP-1R signaling in the pathophysiology of neuropathic pain. Methods: Spinal nerve ligation (SNL) was performed to induce neuropathic pain in rats. Mechanical allodynia was assessed using von Frey filaments. The expression of IL-10, ß-endorphin, and µ-opioid receptor (MOR) was examined by real-time quantitative polymerase chain reaction (qPCR) and whole-cell recording. Measurements of cellular excitability of the substantia gelatinosa (SG) neurons by whole-cell recording were carried out. R packages of differential gene expression analysis based on the negative binomial distribution (DESeq2) and weighted correlation network analysis (WGCNA) were used to analyze differential gene expression and the correlated modules among GLP-1R clusters in neuropathic pain. Results: The GLP-1R agonist, exenatide, has an antiallodynic effect on neuropathic pain, which could be reversed by intrathecal injections of the microglial inhibitor minocycline. Furthermore, differential gene expression analysis (WGCNA) indicated that intrathecal injections of exenatide could reverse the abnormal expression of 591 genes in the spinal dorsal horn induced by nerve injury. WGCNA revealed 58 modules with a close relationship between the microglial GLP-1R pathway and features of nerve injuries, including pain, ligation, paw withdrawal latency (PWL), and anxiety. The brown module was identified as the highest correlated module, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that inflammatory responses were most correlated with PWL. To further unravel the changes of hyperalgesia-related neuronal electrophysiological activity mediated by microglia GLP-1 receptors, whole-cell recording identified that MOR agonism stimulated a robust outward current in the sham groups compared with the spinal nerve ligation (SNL) groups. This inhibitory effect on the SNL group was more sensitive than that of the sham group after bath application of ß-endorphin. Conclusions: Our results further confirmed that the GLP-1R pathway is involved in alleviating pain hypersensitivity mediated by spinal microglia activation, and inflammatory responses were the most correlated pathway associated with PWL changes in response to exenatide treatment. We found that the identification of gene regulation in response to GLP-1R activation is an effective strategy for identifying new therapeutic targets for neuropathic pain. Investigation for the activation of spinal microglial GLP-1R which might ameliorate inflammatory responses through gene expression and structural changes is providing a potential biomarker in pain management.


Subject(s)
Glucagon-Like Peptide-1 Receptor/metabolism , Inflammation Mediators/metabolism , Microglia/metabolism , Neuralgia/metabolism , Signal Transduction/physiology , Animals , Exenatide/administration & dosage , Gene Expression Regulation/physiology , Glucagon-Like Peptide-1 Receptor/agonists , Glucagon-Like Peptide-1 Receptor/genetics , Injections, Spinal , Male , Microglia/drug effects , Neuralgia/drug therapy , Neuralgia/genetics , Rats , Rats, Wistar , Signal Transduction/drug effects , Spinal Nerves/drug effects , Spinal Nerves/injuries , Spinal Nerves/metabolism
5.
Toxicol Appl Pharmacol ; 429: 115698, 2021 10 15.
Article in English | MEDLINE | ID: mdl-34428447

ABSTRACT

In view of postsynaptic density 95kDA (PSD95) tethers neuronal NO synthase (nNOS) to N-methyl-d-aspartate receptor (NMDAR), the PSD95-nNOS complex represents a therapeutic target of neuropathic pain. This study therefore sought to explore the ability of PCC-0105002, a novel PSD95-nNOS small molecule inhibitor, to alter pain sensitivity in rodent neuropathic pain models. Firstly, the IC50 of PCC-0105002 for PSD95 and NOS1 binding activity was determined using an Alpha Screen assay kit. Then, we examined the effects of PCC-0105002 in the mouse formalin test and in the rat spinal nerve ligation (SNL) model, and explored the ability of PCC-0105002 to mediate analgesia and to effect motor coordination in a rota-rod test. Moreover, the mechanisms whereby PCC-0105002 mediates analgesia was explored via western blotting, Golgi staining, and co-immunoprecipitation experiments in dorsal horn. The outcomes indicated that PCC-0105002 exhibited dose-dependent attenuation of phase II pain-associated behaviors in the formalin test. The result indicated that PCC-0105002 disrupted the PSD95-nNOS interaction with IC50 of 1.408 µM. In the SNL model, PCC-0105002 suppressed mechanical allodynia, thermal hyperalgesia, and abnormal dorsal horn wide dynamic range neuron discharge. PCC-0105002 mediated an analgesic effect comparable to that of MK-801, while it was better able to enhance motor coordination as compared with MK-801. Moreover, PCC-0105002 altered signaling downstream of NMDAR and thus functionally and structurally attenuating synaptic plasticity through respective regulation of the NR2B/GluR1/CaMKIIα and Rac1/RhoA pathways. These findings suggest that the novel PSD95-nNOS inhibitor PCC-0105002 is an effective agent for alleviating neuropathic pain, and that it produces fewer motor coordination-associated side effects than do NMDAR antagonists.


Subject(s)
Aminobenzoates/therapeutic use , Analgesics/pharmacology , Disks Large Homolog 4 Protein/metabolism , Esters/therapeutic use , Motor Activity/drug effects , Neuralgia/drug therapy , Nitric Oxide Synthase Type I/metabolism , Posterior Horn Cells/drug effects , Spinal Nerves/drug effects , Aminobenzoates/pharmacology , Analgesics/toxicity , Animals , Disease Models, Animal , Esters/pharmacology , Male , Mice , Neuralgia/enzymology , Neuralgia/physiopathology , Neuronal Plasticity/drug effects , Posterior Horn Cells/enzymology , Protein Binding , Protein Interaction Domains and Motifs , Rats, Sprague-Dawley , Rotarod Performance Test , Signal Transduction , Spinal Nerves/enzymology , Spinal Nerves/physiopathology
6.
Molecules ; 26(10)2021 May 14.
Article in English | MEDLINE | ID: mdl-34069033

ABSTRACT

Nonsteroidal anti-inflammatory drugs (NSAIDs) are very commonly used, but their adverse effects warrant investigating new therapeutic alternatives. Polyalthic acid, a labdane-type diterpenoid, is known to produce gastroprotection, tracheal smooth muscle relaxation, and antitumoral, antiparasitic and antibacterial activity. This study aimed to evaluate the antinociceptive, antiallodynic, antihyperalgesic and anti-inflammatory effect of polyalthic acid on rats. Moreover, the effectiveness of treating hyperalgesia with a combination of polyalthic acid and naproxen was analyzed, as well as the type of drug-drug interaction involved. Nociception was examined by injecting 1% formalin into the right hind paw and thermal hyperalgesia and inflammation by injecting a 1% carrageenan solution into the left hind paw of rats. Allodynia was assessed on an L5/L6 spinal nerve ligation model. Polyalthic acid generated significant antinociceptive (56-320 mg/kg), antiallodynic (100-562 mg/kg), and antihyperalgesic and anti-inflammatory (10-178 mg/kg) effects. Antinociception mechanisms were explored by pretreating the rats with naltrexone, ODQ and methiothepin, finding the effect blocked by the former two compounds, which indicates the participation of opioid receptors and guanylate cyclase. An isobolographic analysis suggests synergism between polyalthic acid and naproxen in the combined treatment of hyperalgesia.


Subject(s)
Analgesics/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Diterpenes/therapeutic use , Hyperalgesia/drug therapy , Administration, Oral , Analgesics/pharmacology , Animals , Anti-Inflammatory Agents/pharmacology , Diterpenes/administration & dosage , Diterpenes/chemistry , Diterpenes/pharmacology , Dose-Response Relationship, Drug , Drug Synergism , Female , Ligation , Naproxen/pharmacology , Naproxen/therapeutic use , Rats, Wistar , Spinal Nerves/drug effects , Time Factors
7.
J Neuroimmunol ; 355: 577552, 2021 06 15.
Article in English | MEDLINE | ID: mdl-33845282

ABSTRACT

A 43 year-old male presented with a relapsing and progressive systemic inflammatory disorder with central nervous system (CNS) involvement. After a two years follow up, he was diagnosed with hemophagocytic lymphohistiocytosis (HLH), based on clinical, laboratory and radiological findings. Treatment was started with anakinra, a recombinant humanised interleukin-1 (IL-1) receptor antagonist. Clinical response was good. Laboratory and radiological findings showed no disease activity throughout a five years follow-up period. Several immunosuppressive agents have been used in HLH without any good outcomes. This is the first case report of HLH with CNS involvement responsive to chronic treatment with anakinra.


Subject(s)
Brain/diagnostic imaging , Interleukin 1 Receptor Antagonist Protein/administration & dosage , Lymphohistiocytosis, Hemophagocytic/diagnostic imaging , Lymphohistiocytosis, Hemophagocytic/drug therapy , Spinal Nerves/diagnostic imaging , Adult , Brain/drug effects , Brain/metabolism , Follow-Up Studies , Humans , Interleukin 1 Receptor Antagonist Protein/metabolism , Lymphohistiocytosis, Hemophagocytic/metabolism , Male , Receptors, Interleukin-1/agonists , Receptors, Interleukin-1/metabolism , Recurrence , Spinal Nerves/drug effects , Spinal Nerves/metabolism , Treatment Outcome
8.
Neuroreport ; 32(6): 450-457, 2021 04 07.
Article in English | MEDLINE | ID: mdl-33657074

ABSTRACT

Spinal cord injury (SCI) leads to permanent loss of motor and sensory function due to the complex mechanisms of the external microenvironment and internal neurobiochemistry that restrict neuronal plasticity and axonal regeneration. Chemokine CXCL12 was verified in regulating the development of central nervous system (CNS) and repairing of CNS disease. In the present study, CXCL12 was downregulated in the spinal cord after SCI. SCI also induced gliosis and loss of synapse. Intrathecal treatment of CXCL12 promoted the functional recovery of SCI by inducing the formation of neuronal connections and suppressing glia scar. To confirm whether CXCL12 promoted synapse formation and functional neuronal connections, the primary cortical neurons were treated with CXCL12 peptide, the synapse was examined using Immunofluorescence staining and the function of synapse was tested using a whole-cell patch clamp. The results indicated that CXCL12 peptide promoted axonal elongation, branche formation, dendrite generation and synaptogenesis. The electrophysiological results showed that CXCL12 peptide increased functional connections among neurons. Taken together, the present study illustrated an underlying mechanism of the development of SCI and indicated a potential approach to facilitate functional recovery of spinal cord after SCI.


Subject(s)
Chemokine CXCL12/genetics , Nerve Regeneration/genetics , Neurons/physiology , Recovery of Function/genetics , Spinal Cord Injuries/genetics , Spinal Nerves/physiology , Synapses/physiology , Animals , Cerebral Cortex/cytology , Chemokine CXCL12/metabolism , Chemokine CXCL12/pharmacology , Down-Regulation , Gliosis/genetics , Nerve Regeneration/drug effects , Neuronal Outgrowth/drug effects , Neuronal Outgrowth/physiology , Neurons/drug effects , Patch-Clamp Techniques , Rats , Real-Time Polymerase Chain Reaction , Recovery of Function/drug effects , Spinal Cord Injuries/metabolism , Spinal Nerves/drug effects , Synapses/drug effects
9.
Mol Pain ; 17: 1744806921997654, 2021.
Article in English | MEDLINE | ID: mdl-33626989

ABSTRACT

Neuropathic pain is a severe problem that is difficult to treat clinically. Reducing abnormal remodeling of dendritic spines/synapses and increasing the anti-inflammatory effects in the spinal cord dorsal horn are potential methods to treat this disease. Previous studies have reported that electroacupuncture (EA) could increase the pain threshold after peripheral nerve injury. However, the underlying mechanism is unclear. P2X7 receptors (P2X7R) mediate the activation of microglia and participate in the occurrence and development of neuropathic pain. We hypothesized that the effects of EA on relieving pain may be related to the downregulation of the P2X7R. Spinal nerve ligation (SNL) rats were used as a model in this experiment, and 2'(3')-O-(4-benzoyl)benzoyl ATP (BzATP) was used as a P2X7R agonist. We found that EA treatment decreased dendritic spine density, inhibited synaptic reconstruction and reduced inflammatory response, which is consistent with the decrease in P2X7R expression as well as the improved neurobehavioral performance. In contrast to the beneficial effects of EA, BzATP enhanced abnormal remodeling of dendritic spines/synapses and inflammation. Furthermore, the EA-mediated positive effects were reversed by BzATP, which is consistent with the increased P2X7R expression. These findings indicated that EA improves neuropathic pain by reducing abnormal dendritic spine/synaptic reconstruction and inflammation via suppressing P2X7R expression.


Subject(s)
Electroacupuncture , Neuralgia/metabolism , Neuralgia/therapy , Receptors, Purinergic P2X7/metabolism , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/pharmacology , Animals , Dendritic Spines/drug effects , Inflammation Mediators/metabolism , Ligation , Male , Models, Biological , Nerve Tissue Proteins/metabolism , Neuralgia/physiopathology , Neuronal Plasticity/drug effects , Neurons/drug effects , Neurons/pathology , Pain Threshold/drug effects , Rats, Sprague-Dawley , Spinal Cord Dorsal Horn/drug effects , Spinal Cord Dorsal Horn/pathology , Spinal Nerves/drug effects , Spinal Nerves/pathology , Spinal Nerves/physiopathology
10.
Pharmacol Res Perspect ; 8(5): e00663, 2020 10.
Article in English | MEDLINE | ID: mdl-32965798

ABSTRACT

The antiallodynic effect of PhAR-DBH-Me was evaluated on two models of neuropathic pain, and the potential roles of CB1, CB2, and TRPV1 receptors as molecular targets of PhAR-DBH-Me were studied. Female Wistar rats were submitted to L5/L6 spinal nerve ligation (SNL) or repeated doses of cisplatin (0.1 mg/kg, i.p.) to induce experimental neuropathy. Then, tactile allodynia was determined, and animals were treated with logarithmic doses of PhAR-DBH-Me (3.2-100 mg/kg, i.p.). To evaluate the mechanism of action of PhAR-DBH-Me, in silico studies using crystallized structures of CB1, CB2, and TRPV1 receptors were performed. To corroborate the computational insights, animals were intraperitoneally administrated with antagonists for CB1 (AM-251, 3 mg/kg), CB2 (AM-630, 1 mg/kg), and TRPV1 receptors (capsazepine, 3 mg/kg), 15 min before to PhAR-DBH-Me (100 mg/kg) administration. Vagal stimulation evoked on striated muscle contraction in esophagus, was used to elicited pharmacological response of PhAR-DBH-ME on nervous tissue. Systemic administration of PhAR-DBH-Me reduced the SNL- and cisplatin-induced allodynia. Docking studies suggested that PhAR-DBH-Me acts as an agonist for CB1, CB2, and TRPV1 receptors, with similar affinity to the endogenous ligand anandamide. Moreover antiallodynic effect of PhAR-DBH-Me was partially prevented by administration of AM-251 and AM-630, and completely prevented by capsazepine. Finally, PhAR-DBH-Me decreased the vagally evoked electrical response in esophagus rat. Taken together, results indicate that PhAR-DBH-Me induces an antiallodynic effect through partial activation of CB1 and CB2 receptors, as well as desensitization of TRPV1 receptors. Data also shed light on the novel vanilloid nature of the synthetic compound PhAR-DBH-Me.


Subject(s)
Azabicyclo Compounds/pharmacology , Cannabinoid Receptor Antagonists/pharmacology , Hyperalgesia/chemically induced , Oleic Acids/pharmacology , TRPV Cation Channels/drug effects , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Arachidonic Acids/metabolism , Azabicyclo Compounds/administration & dosage , Cannabinoid Receptor Antagonists/metabolism , Capsaicin/administration & dosage , Capsaicin/analogs & derivatives , Capsaicin/pharmacology , Cisplatin/administration & dosage , Cisplatin/adverse effects , Endocannabinoids/metabolism , Female , Hyperalgesia/drug therapy , Injections, Intraperitoneal , Ligation/methods , Models, Animal , Neuralgia/chemically induced , Neuralgia/drug therapy , Oleic Acids/administration & dosage , Polyunsaturated Alkamides/metabolism , Rats , Rats, Wistar , Spinal Nerves/drug effects , Spinal Nerves/surgery , TRPV Cation Channels/antagonists & inhibitors , Vagus Nerve Stimulation/methods
11.
World Neurosurg ; 144: e849-e855, 2020 12.
Article in English | MEDLINE | ID: mdl-32956890

ABSTRACT

OBJECTIVE: This study aimed to compare the ultrasound (US)-guided erector spinae plane block (ESPB) and modified-thoracolumbar interfascial plane (mTLIP) block for postoperative pain management in lumbar discectomy surgery patients. METHODS: A total of 90 patients scheduled for lumbar discectomy were randomly assigned into 3 groups (n = 30 per group): an ESPB group, an mTLIP group, and a control group. In the ESPB and mTLIP groups, a single-shot US-guided block was administered with 20 mL of 0.25% bupivacaine bilaterally. All patients received intravenous patient-controlled postoperative analgesia with fentanyl, and 1 g intravenous paracetamol every 6 hours. Fentanyl consumption, Visual Analog Scale (VAS) pain scores, rescue analgesia, block procedure time, and side-effects were evaluated. RESULTS: Postoperative opioid consumption at all time intervals were significantly lower both in ESPB and mTLIP groups compared with the control group (P < 0.05). No significant difference was observed concerning intra- and postoperative opioid consumption between the ESPB and the mTLIP group (P < 0.001). Passive VAS score at the postanesthesia care unit, second, fourth, and eighth hours, and active VAS score at the postanesthesia care unit, second, fourth, eighth, and 16th hours were significantly lower in the ESPB and mTLIP groups compared with the control group (P < 0.05). The use of rescue analgesia was significantly lower in the ESPB and mTLIP groups than in the control group (9/30, 7/30, and 21/30, respectively, P < 0.001). The block procedure time was similar between groups (P = 0.198). CONCLUSIONS: US-guided ESPB and mTLIP block may provide adequate pain control after discectomy surgery. However, there is a nonsuperiority between ESPB and the mTLIP groups.


Subject(s)
Diskectomy/methods , Nerve Block/methods , Pain, Postoperative/prevention & control , Ultrasonography, Interventional/methods , Adult , Analgesics, Opioid/therapeutic use , Diskectomy/adverse effects , Female , Humans , Lumbar Vertebrae/surgery , Male , Middle Aged , Pain, Postoperative/etiology , Spinal Nerves/drug effects , Treatment Outcome
12.
Mol Pain ; 16: 1744806920950866, 2020.
Article in English | MEDLINE | ID: mdl-32811276

ABSTRACT

The glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) alleviate symptoms of experimental neuropathy, protect and stimulate regeneration of sensory neurons in animal models of neuropathic pain, and restore their functional activity. However, clinical development of GFL proteins is complicated by their poor pharmacokinetic properties and multiple effects mediated by several receptors. Previously, we have identified a small molecule that selectively activates the major signal transduction unit of the GFL receptor complex, receptor tyrosine kinase RET, as an alternative to GFLs, for the treatment of neuropathic pain. We then introduced a series of chemical changes to improve the biological activity of these compounds and tested an optimized compound named BT44 in a panel of biological assays. BT44 efficiently and selectively stimulated the GFL receptor RET and activated the intracellular mitogene-activated protein kinase/extracellular signal-regulated kinase pathway in immortalized cells. In cultured sensory neurons, BT44 stimulated neurite outgrowth with an efficacy comparable to that of GFLs. BT44 alleviated mechanical hypersensitivity in surgery- and diabetes-induced rat models of neuropathic pain. In addition, BT44 normalized, to a certain degree, the expression of nociception-related neuronal markers which were altered by spinal nerve ligation, the neuropathy model used in this study. Our results suggest that the GFL mimetic BT44 is a promising new lead for the development of novel disease-modifying agents for the treatment of neuropathy and neuropathic pain.


Subject(s)
Biomimetics/methods , Neuralgia/drug therapy , Proto-Oncogene Proteins c-ret/agonists , Proto-Oncogene Proteins c-ret/metabolism , Sensory Receptor Cells/drug effects , Signal Transduction/drug effects , Spinal Nerves/drug effects , Animals , Behavior Rating Scale , Cell Line , Diabetic Neuropathies/drug therapy , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Glial Cell Line-Derived Neurotrophic Factor Receptors/metabolism , Glial Cell Line-Derived Neurotrophic Factors , Immunohistochemistry , Male , Nerve Tissue Proteins/metabolism , Neuralgia/metabolism , Nociception/drug effects , Phosphorylation , Rats , Rats, Wistar , Sensory Receptor Cells/metabolism , Spinal Nerves/injuries
13.
Sci Rep ; 10(1): 11508, 2020 07 13.
Article in English | MEDLINE | ID: mdl-32661332

ABSTRACT

The potential paravertebral space includes spinal nerves, dorsal rami, rami communicants, and sympathetic chains. This study evaluated correlations between paravertebral spread of injectate and clinical efficacy in lumbar transforaminal block. We retrospectively analysed the data of 88 patients who received transforaminal blocks for lumbar radicular pain. We categorized patients into two groups: patients with ≥ 50% pain reduction on a numeric rating scale at 30 min following a block (responder group), and patients with < 50% pain reduction (non-responder group). Paravertebral spread of injectate was graded as limited to the anterior, middle, and posterior 1/3 of the anterolateral aspect of vertebral bodies; spread between the posterolateral margins of bodies and the posterior epidural space was considered no spread. Clinical and fluoroscopic data, perfusion index, temperature, and cold sensation were compared between the groups. Among 54 patients analysed, 26 (48.1%) experienced ≥ 50% and 28 (51.9%) < 50% pain reduction. Paravertebral spread occurred in 33 (61.1%) patients; 19 (57.6%) responders and 14 (42.4%) non-responders. On analysis, paravertebral spread, epidural spread patterns, perfusion index change ratios, temperature changes, and cold sensation changes showed no differences between responder and non-responder groups. Paravertebral spread occurred in 61.1%, with no correlation with the clinical efficacy of lumbar transforaminal block.


Subject(s)
Back Pain/drug therapy , Epidural Space/drug effects , Low Back Pain/drug therapy , Nerve Block/methods , Adult , Aged , Aged, 80 and over , Back Pain/physiopathology , Female , Fluoroscopy , Humans , Low Back Pain/physiopathology , Lumbosacral Region/physiopathology , Male , Middle Aged , Retrospective Studies , Spinal Nerves/drug effects , Treatment Outcome
14.
Mol Med Rep ; 22(3): 1921-1931, 2020 09.
Article in English | MEDLINE | ID: mdl-32705167

ABSTRACT

A significant decrease in the expression of spinal microRNA­29c (miR­29c), which is responsible for the regulation of oxytocin receptor (OXTR) expression, was observed in nerve injury pain during childbirth. The present study investigates whether spinal miR­29c could be a potential target for the treatment of pain, via the oxytocin (OT)­Î³­aminobutyric acid (GABA) pathway. A spared nerve injury (SNI) rat model was established to induce neuropathic pain, simulating hyperalgesia. Spinal neurons were treated with OT to mimic the hormonal changes in the central nervous system after delivery. A change in the neuronal miniature inhibitory postsynaptic currents (mIPSCs) was observed in neurons, following the silencing of miR­29c or OT treatment with or without OXTR antagonist. The Von­Frey apparatus was used to measure the animal behaviors. Molecular biological experiments and electrophysical recordings in vivo and in vitro were performed to reveal the potential analgesic mechanisms. miR­29c was significantly downregulated (more than 8­fold) in the spinal dorsal horn of delivery+SNI rats compared with the SNI rats. The silencing of miR­29c resulted in increased pain threshold in SNI rats. Bioinformatics analysis indicated that OXTR was a potential target gene of miR­29c. The delivery+SNI rats presented with higher levels of OT in the cerebrospinal fluid compared with SNI rats, which indicated that the OT signaling pathway may participate in pain relief response. The increased expression of OXTR and GABA in delivery+SNI rats were observed in the miR­29c­silenced SNI rat model, suggesting that the silencing of miR­29c can mediate pain relief by enhancing the OT­GABA pathway. In addition, an electrophysiology assay was performed to assess the mIPSCs in neurons. The silencing of miR­29c in neurons increased the frequency and amplitude of mIPSCs but there was no influence on the decay time, which suggested that the spinal inhibitory neurons became more active, subsequently reducing the feeling of pain. The inhibition of OXTR reversed the enhanced inhibitory postsynaptic currents, indicating a crucial role for OXTR in the miR­29c­associated pain regulation. Taken together, the results of the present study suggested that spinal oxytocinergic inhibitory control plays an important role in pain relief in the neuropathic pain rat model undergoing vaginal delivery. Silencing spinal miR­29c may be a potential target for pain relief through the OT­GABA pathway.


Subject(s)
Down-Regulation , Labor Pain/genetics , MicroRNAs/genetics , Oxytocin/pharmacology , Receptors, Oxytocin/genetics , Spinal Nerves/cytology , Animals , Cells, Cultured , Disease Models, Animal , Female , Gene Silencing , Labor Pain/therapy , Pregnancy , Primary Cell Culture , Rats , Signal Transduction , Spinal Nerves/drug effects , Spinal Nerves/metabolism , gamma-Aminobutyric Acid/metabolism
15.
Pain Physician ; 23(3): E305-E314, 2020 06.
Article in English | MEDLINE | ID: mdl-32517407

ABSTRACT

BACKGROUND: The costotransverse foramen (CTF) is a space continuous with the paravertebral space. We hypothesized that injections passing through the CTF will result in a successful injectate spread to the paravertebral space. OBJECTIVES: We investigated patterns of dye spread to assess characteristics of neural blockade following ultrasound-guided CTF and erector spinae plane (ESP) injection in an anatomic and clinical study. STUDY DESIGN: Prospective cadaveric study, and case studies. SETTING: University hospital. METHODS: Six soft cadavers were studied. The boundaries of the CTF and the needle pathway of CTF injection were identified in the first cadaver. The CTF and ESP injections were performed on either the left or right sides of the T4 vertebral level in cadavers 2 to 6. Fifteen milliliters of 0.2% methylene blue was injected in each block, and the spread of dye was assessed by anatomic dissection. We also report 2 case studies of CTF and ESP blocks. RESULTS: Cadaver studies of CTF injection demonstrate that with injection to the inferior aspect of the base of the transverse process, the dye mainly passes anteriorly through the CTF into the paravertebral space, with minimal track-back to the deep back muscles. Consistent sensory blockade was achieved in 2 case studies. With the ESP injection, the spread of dye was observed cephalocaudad to the fascia of the erector spinae muscle, with no dye spreading within the paravertebral space in all cadavers. LIMITATIONS: Prospective case series. CONCLUSIONS: CTF block was consistently associated with a mainly anterior spread of injectate into the paravertebral space that involved the thoracic spinal nerves, and minimal posterior spread of injectate to the deep back muscles. KEY WORDS: Thoracic vertebrae, rib cage, paraspinal muscle, nerve block, joints.


Subject(s)
Nerve Block/methods , Paraspinal Muscles , Spinal Nerves , Thoracic Vertebrae , Ultrasonography, Interventional/methods , Cadaver , Female , Humans , Injections , Male , Paraspinal Muscles/drug effects , Paraspinal Muscles/innervation , Spinal Nerves/anatomy & histology , Spinal Nerves/drug effects , Thoracic Vertebrae/anatomy & histology , Thoracic Vertebrae/drug effects
16.
Int J Mol Sci ; 21(10)2020 May 14.
Article in English | MEDLINE | ID: mdl-32423102

ABSTRACT

Activation of CX3CR1 in microglia plays an important role in the development of neuropathic pain. Here, we investigated whether neuropathic pain could be attenuated in spinal nerve ligation (SNL)-induced rats by reducing microglial activation through the use of poly(D,L-lactic-co-glycolic acid) (PLGA)-encapsulated CX3CR1 small-interfering RNA (siRNA) nanoparticles. After confirming the efficacy and specificity of CX3CR1 siRNA, as evidenced by its anti-inflammatory effects in lipopolysaccharide-stimulated BV2 cells in vitro, PLGA-encapsulated CX3CR1 siRNA nanoparticles were synthesized by sonication using the conventional double emulsion (W/O/W) method and administered intrathecally into SNL rats. CX3CR1 siRNA-treated rats exhibited significant reductions in the activation of microglia in the spinal dorsal horn and a downregulation of proinflammatory mediators, as well as a significant attenuation of mechanical allodynia. These data indicate that the PLGA-encapsulated CX3CR1 siRNA nanoparticles effectively reduce neuropathic pain in SNL-induced rats by reducing microglial activity and the expression of proinflammatory mediators. Therefore, we believe that PLGA-encapsulated CX3CR1 siRNA nanoparticles represent a valuable new treatment option for neuropathic pain.


Subject(s)
CX3C Chemokine Receptor 1/genetics , Nanoparticles/chemistry , Neuralgia/drug therapy , RNA, Small Interfering/pharmacology , Spinal Nerves/drug effects , Animals , Behavior, Animal/drug effects , CX3C Chemokine Receptor 1/antagonists & inhibitors , Humans , Ligation , Lipopolysaccharides/pharmacology , Macrophage Activation/drug effects , Microglia/drug effects , Neuralgia/genetics , Neuralgia/pathology , Pain Management , Pain Measurement/methods , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Polylactic Acid-Polyglycolic Acid Copolymer/pharmacology , RNA, Small Interfering/genetics , Rats , Spinal Cord/drug effects , Spinal Cord/pathology , Spinal Cord Dorsal Horn/drug effects , Spinal Cord Dorsal Horn/pathology , Spinal Nerves/metabolism , Spinal Nerves/pathology
17.
Rev. Soc. Esp. Dolor ; 27(2): 127-132, mar.-abr. 2020. ilus, tab
Article in Spanish | IBECS | ID: ibc-195854

ABSTRACT

El manejo del dolor es una pieza crítica en el cuidado general del niño quemado. El dolor neuropático es una de sus consecuencias frecuentes, el cual puede aparecer al inicio o durante el proceso de cicatrización de heridas, acompañándose de sintomatología predominantemente por estimulación del sistema nervioso simpático, siendo su manejo un reto importante. El bloqueo del plano del erector espinal (ESP) es una técnica regional novedosa que se ha utilizado en diferentes tipos de cirugía, con resultados prometedores. Actualmente, el bloqueo ESP en la población pediátrica se viene realizando para cirugías de tórax, abdomen, cadera y genitales, con solo pocos informes. Hasta donde sabemos, el bloqueo ESP para dolor neuropático en niños aún no se ha reportado. El presente informe sugiere que el bloqueo ESP torácico realizado a nivel T4 podría proporcionar una analgesia amplia y efectiva en el dolor neuropático además de regular la sintomatología simpática, secundaria a los cambios fisiopatológicos relacionados con el grado de quemadura


Pain management is a critical piece in the general care of the burned child. Neuropathic pain is one of its frequent consequences, which may appear at the beginning or during the wound healing process, accompanied by symptoms predominantly due to stimulation of the sympathetic nervous system, its management being an important challenge. The spinal erector plane (ESP) block is a novel regional technique that has been used in different types of surgery, with promising results. Currently, the ESP block in the pediatric population has been performed for thorax, abdomen, hip and genital surgeries, with only a few reports. As far as we know, ESP block for neuropathic pain in children has not yet been reported. The present report suggests that the thoracic ESP blockade performed at the T4 level could provide a wide and effective analgesia in neuropathic pain in addition to regulating sympathetic symptomatology, secondary to the pathophysiological changes related to the degree of burn


Subject(s)
Humans , Female , Infant , Nerve Block/methods , Spinal Nerves/drug effects , Burns/complications , Neuralgia/drug therapy , Anesthesia, Local/methods , Burns/drug therapy , Pain Management/methods , Dipyrone/administration & dosage , Tramadol/administration & dosage , Morphine/administration & dosage
18.
J Comp Neurol ; 528(13): 2195-2217, 2020 09 01.
Article in English | MEDLINE | ID: mdl-32064609

ABSTRACT

Fifth lumbar (L5) nerve injury in rats causes neuropathic pain manifested with thermal and mechanical hypersensitivity in the ipsilateral hind paw. This study aimed to determine whether the elimination of unmyelinated primary afferents of the adjacent uninjured nerves (L3 and L4) would alleviate peripheral neuropathic pain. Different concentrations of capsaicin or its analog, resiniferatoxin (RTX), were applied perineurally on either the left L4 or L3 and L4 nerves in Wistar rats whose left L5 nerves were ligated and cut. The application of both capsaicin and RTX on the L4 nerve significantly reduced both thermal and mechanical hypersensitivity. However, only the application of RTX on both L3 and L4 nerves completely alleviated all neuropathic manifestations. Interestingly, responses to thermal and mechanical stimuli were preserved, despite RTX application on uninjured L3, L4, and L5 nerves, which supply the plantar skin in rats. Perineural application of RTX caused downregulation of TRPV1, CGRP, and IB4 binding and upregulation of VIP in the corresponding dorsal root ganglia (DRG) and the dorsal horn of the spinal cord. In comparison, VGLUT1 and NPY immunoreactivities were not altered. RTX application did not cause degenerative or ultrastructural changes in the treated nerves and corresponding DRGs. The results demonstrate that RTX induces neuroplasticity, rather than structural changes in primary afferents, that are responsible for alleviating hypersensitivity and chronic pain. Furthermore, this study suggests that treating uninjured adjacent spinal nerves may be used to manage chronic neuropathic pain following peripheral nerve injury.


Subject(s)
Diterpenes/administration & dosage , Ganglia, Spinal/drug effects , Hot Temperature/adverse effects , Hyperalgesia/prevention & control , Neurotoxins/administration & dosage , Touch , Animals , Ganglia, Spinal/injuries , Ganglia, Spinal/metabolism , Hyperalgesia/metabolism , Hyperalgesia/pathology , Lumbar Vertebrae , Male , Pain Measurement/drug effects , Pain Measurement/methods , Peripheral Nerves/drug effects , Peripheral Nerves/metabolism , Peripheral Nerves/pathology , Rats , Rats, Wistar , Spinal Nerves/drug effects , Spinal Nerves/injuries , Spinal Nerves/metabolism
19.
Anesthesiology ; 132(4): 881-894, 2020 04.
Article in English | MEDLINE | ID: mdl-31977518

ABSTRACT

BACKGROUND: The anterior cingulate cortex and central nucleus of the amygdala connect widely with brainstem nuclei involved in descending modulation, including the rostral ventromedial medulla. Endogenous opioids in these circuits participate in pain modulation. The hypothesis was that a differential opioidergic role for the brain nuclei listed in regulation of spinal neuronal responses because separable effects on pain behaviors in awake animals were previously observed. METHODS: This study utilized in vivo electrophysiology to determine the effects of morphine microinjection into the anterior cingulate cortex, right or left central nucleus of the amygdala, or the rostral ventromedial medulla on spinal wide dynamic range neuronal responses in isoflurane-anesthetized, male Sprague-Dawley rats. Ongoing activity in the ventrobasal thalamus was also measured. In total, 33 spinal nerve ligated and 26 control age- and weight-matched control rats were used. RESULTS: Brainstem morphine reduced neuronal firing to 60-g von Frey stimulation in control rats (to 65 ± 12% of control response (means ± 95% CI), P < 0.001) with a greater inhibition in neuropathic rats (to 53 ± 17% of control response, P < 0.001). Contrasting anterior cingulate cortex morphine had only marginal modulatory effects on spinal neuronal responses with limited variance in effect between control and neuropathic rats. The inhibitory effects of morphine in the central nucleus of the amygdala were dependent on pain state and laterality; only right-side morphine reduced neuronal firing to 60-g stimulation in neuropathic rats (to 65 ± 14% of control response, P = 0.001). In addition, in neuropathic rats elevated ongoing neuronal activity in the ventral posterolateral thalamus was not inhibited by anterior cingulate cortex morphine, in contrast to evoked responses. CONCLUSIONS: Cumulatively the data support opioid modulation of evoked responses predominately through a lateralized output from the right amygdala, as well as from the brainstem that is enhanced in injured conditions. Minimal modulation of dorsal horn responses was observed after anterior cingulate cortex opioid administration regardless of injury state.


Subject(s)
Amygdala/drug effects , Analgesics, Opioid/administration & dosage , Morphine/administration & dosage , Nerve Net/drug effects , Peripheral Nervous System Diseases/drug therapy , Spinal Nerves/drug effects , Action Potentials/drug effects , Action Potentials/physiology , Amygdala/physiology , Animals , Dose-Response Relationship, Drug , Gyrus Cinguli/drug effects , Gyrus Cinguli/physiology , Male , Medulla Oblongata/drug effects , Medulla Oblongata/physiology , Microinjections/methods , Nerve Net/physiology , Peripheral Nervous System Diseases/physiopathology , Posterior Horn Cells/drug effects , Posterior Horn Cells/physiology , Rats , Rats, Sprague-Dawley , Spinal Nerves/physiology
20.
J Surg Res ; 246: 19-25, 2020 02.
Article in English | MEDLINE | ID: mdl-31550671

ABSTRACT

BACKGROUND: Some surgeons have adopted the use of video-assisted thoracoscopic surgery (VATS) or robotic surgery to perform resections for lung cancer. VATS is associated with less pain and a decrease in pulmonary complications compared with open thoracotomies. Long-acting liposomal bupivacaine (LB) intercostal nerve blocks are reported to provide superior pain relief compared with epidural catheters in the first 3 d after a thoracotomy. This study examined whether LB improves pain after VATS and if it provides effective analgesia after a thoracotomy. MATERIALS AND METHODS: A retrospective review was performed on 151 consecutive patients undergoing a VATS or thoracotomy who received paravertebral nerve blocks. VATS patients received paravertebral nerve blocks with LB (VATS-LB) or 0.25% bupivacaine with epinephrine (BE; VATS-BE). Thoracotomy patients received paravertebral nerve blocks via LB injections. Pain scores, narcotic utilization, complications, and hospital length of stay were examined. RESULTS: Fifty patients underwent a VATS-LB, 53 underwent a VATS-BE, and 32 underwent a thoracotomy. Thoracotomy and VATS-LB patients had pain scores lower than VATS-BE patients in the first 48 h after surgery (P < 0.004). Opioid use was not significantly different between the thoracotomy and VATS-LB patients throughout the first 2 wk postoperatively. CONCLUSIONS: LB paravertebral blocks significantly improve postoperative pain in comparison with 0.25% BE blocks in VATS patients. LB paravertebral blocks also provide effective analgesia in patients undergoing thoracotomies.


Subject(s)
Nerve Block/methods , Pain Management/methods , Pain, Postoperative/therapy , Thoracic Surgery, Video-Assisted/adverse effects , Thoracotomy/adverse effects , Aged , Anesthetics, Local/administration & dosage , Bupivacaine/administration & dosage , Epinephrine/administration & dosage , Female , Humans , Lung Neoplasms/surgery , Male , Middle Aged , Pain Measurement , Pain, Postoperative/diagnosis , Pain, Postoperative/etiology , Postoperative Care/methods , Retrospective Studies , Spinal Nerves/drug effects , Thoracic Vertebrae/innervation , Treatment Outcome , Vasoconstrictor Agents/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...